Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effects of SPL84 for Patients with Cystic Fibrosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    Czechia France Germany Hungary Italy Lithuania +4
  • Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    Belgium Czechia Denmark Germany Italy The Netherlands +3
  • Evaluation of Safety, Tolerability, and Biodistribution of Inhaled RCT2100 in Cystic Fibrosis: A Phase 1/2 Multicenter Study

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France The Netherlands
  • Study on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor in Children and Adults with Cystic Fibrosis Aged 2 Years and Older

    Not recruiting

    3 1 1 1
    Germany
  • Study on Thymalfasin for Adults with Cystic Fibrosis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on the Safety and Tolerability of Elexacaftor, Tezacaftor, and Ivacaftor in Children with Cystic Fibrosis Aged 12 to Less Than 24 Months

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark Germany The Netherlands
  • Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    Belgium Czechia France Germany Italy The Netherlands +3
  • Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia Denmark France Germany +10
  • Study on VX-522 and Ivacaftor for Adults with Cystic Fibrosis Unresponsive to CFTR Modulator Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Italy The Netherlands Spain Sweden
  • Study on the Safety and Tolerance of BI 1291583 in Adults with Cystic Fibrosis Bronchiectasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium France Germany Italy The Netherlands Spain